Reducing the Harms of Nonclinical Psychedelics Use Through a Peer-Support Telephone Helpline [0.03%]
通过同伴支持电话帮助热线减少非临床式致幻剂使用的危害
Mollie M Pleet,Joshua White,Joseph A Zamaria et al.
Mollie M Pleet et al.
Introduction: A resurgence of interest in the use of psychedelics for mental health and wellness has stimulated greater experimentation with psychedelics in society. Although clinical psychedelic trials protect research p...
A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression [0.03%]
抑郁症死蔵花提取物与埃斯西塔普隆的 bayesian 重新评估研究
Sandeep M Nayak,Bilal A Bari,David B Yaden et al.
Sandeep M Nayak et al.
Objectives: To perform a Bayesian reanalysis of a recent trial of psilocybin (COMP360) versus escitalopram for Major Depressive Disorder (MDD) in order to provide a more informative interpretation of the indeterminate out...